CVRX CVRx, Inc.
$1.39▼ -4.50%
Healthcare
Other
Volume 216.7K
Avg Volume (10D) 373.4K
Key Metrics & Fundamentals
Market Cap
$36.90M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.26 - 11.30
% vs 50 MA
-38.90%
% vs 200 MA
-73.12%
RSI-14
32.3
MACD Histogram
+0.0500
Beta (1Y vs SPY)
0.84
Free Cash Flow
-$8.94M
Gross Rev
$15.71M
Gross Profit
$13.72M
EBITDA
-$12.25M
COGS
$1.98M
Operating Exp
$26.75M
Operating Income
-$13.02M
EBIT
-$13.02M
Pretax Income
-$14.04M
Net Income
-$14.04M
EPS (Diluted)
-0.53
Price & Volume History
Loading chart…
Recent News
CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026
GlobeNewswire · Oct 22, 2026 4:30 PM ET
CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026
GlobeNewswire · Sep 29, 2026 4:30 PM ET
Nyxoah Names Loic Moreau Interim CFO as John Landry Steps Down
MT Newswires · Sep 21, 2026 4:33 PM ET
CVRx Names New Chief Financial Officer
MT Newswires · Sep 21, 2026 4:23 PM ET
CVRx Appoints John Landry as Chief Financial Officer
GlobeNewswire · Sep 21, 2026 4:07 PM ET
Beta Bionics, Inc. (BBNX) Surges 15.3%: Is This an Indication of Further Gains?
Zacks · Sep 17, 2026 6:21 AM ET
CVRx Secures Devoted Health Coverage for Barostim Therapy
Zacks · Aug 28, 2026 11:39 AM ET
CVRx Responds to Letter from Pointillist Family Office
GlobeNewswire · Aug 25, 2026 8:00 AM ET
CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy
GlobeNewswire · Aug 24, 2026 8:30 AM ET
Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer
PR Newswire · Aug 24, 2026 8:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CVRX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.